Indian Immunologicals Limited (IIL), one of India's leading vaccine manufacturers, has issued a clarification regarding recent reports surrounding its human anti-rabies vaccine, Abhayrab®. The company strongly refuted the over-cautious and misplaced reference to 2023 made in a recent Australian health advisory, stressing that advisory does not reflect the current situation.